bioAffinity Technologies, Inc. announced that Sandeep Bansal, M.D., Medical Director of Lung Innovations Network, has joined the Company?s Medical and Scientific Advisory Board to provide expert advice and counsel on bioAffinity Technology products and research. Lung Innovations Network, a patient-centered practice that offers comprehensive lung care to over 10,000 patients in central and western Pennsylvania, will incorporate CyPath® Lung into its practice to aid in the detection of early-stage lung cancer. Dr. Bansal has extensive experience in minimally invasive pulmonary procedures including navigational and robotic bronchoscopy, endobronchial ultrasound and chest sonography, argon plasma coagulation, cryotherapy, airway stenting, bronchoscopic lung volume reduction and indwelling pleural catheters.

A principal investigator of multiple clinical research trials and a journal reviewer for several medical journals, he has been instrumental in developing a comprehensive lung center that allows a rapid assessment and management of healthcare needs based on the population characteristics and available resources. The model has been very successful in bringing advanced pulmonary services, including the latest technology and population health services, including a robust lung cancer screening program, to support the region?s clinical needs.